Table 1 Content of follow-up at different time points post-PCI

Daily living conditions

 Low-salt and low-fat diet

 Proper exercise

 Quit smoking

 Quit drinking

Medications

 Use of medications for secondary prevention of CHD

  Antiplatelet agents

  Statins

  ACEI/ARB

  β blocker

 Medications meet the recommended dose

  ACEI/ARB

  β blocker

Control of risk factors

 Blood pressure(≤ 130/80 mmHg)

 Blood glucose

  Fasting blood glucose ≤ 6.0 mmol/L

  2 h postprandial blood glucose ≤ 11.0 mmol/L

  Glycosylated hemoglobin ≤ 6.5%

 LDL-C(≤ 1.4 mmol/L)

Outcomes

 In-stent restenosis

 Severe ventricular arrhythmia

 Heart failure

 Recurrent angina pectoris

 Sudden cardiac death

 No reflow

 Atrial fibrillation

 Death from other causes other than cardiac death

 Stroke/cerebrovascular accident